Eledon Pharmaceuticals, Inc. Research and Development Expense
Eledon Pharmaceuticals, Inc. (ELDN) reported Research and Development Expense of $18.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- Eledon Pharmaceuticals, Inc. research and development expense for the quarter ending 2026-06-30 was $18.23M, a 10.09% decline year-over-year.
- Eledon Pharmaceuticals, Inc. research and development expense for the quarter ending 2026-03-31 was $17.20M, a 27.09% increase year-over-year.
- Eledon Pharmaceuticals, Inc. research and development expense for the quarter ending 2025-12-31 was $17.49M, a 2.44% decline year-over-year.
- Eledon Pharmaceuticals, Inc. research and development expense for the quarter ending 2025-09-30 was $14.97M, a 9.39% decline year-over-year.
- Eledon Pharmaceuticals, Inc. research and development expense for fiscal 2025 was $66.27M, a 27.52% increase from fiscal 2024.
- Eledon Pharmaceuticals, Inc. research and development expense for fiscal 2024 was $51.96M, a 71.43% increase from fiscal 2023.
- Eledon Pharmaceuticals, Inc. research and development expense for fiscal 2023 was $30.31M, a 11.94% increase from fiscal 2022.
- Eledon Pharmaceuticals, Inc. research and development expense for fiscal 2022 was $27.08M, a 14.09% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $18.23M 10-Q · filed 2026-08-13 | $35.43M 10-Q · filed 2026-08-13 | $52.92M derived: sum of 3 quarters · filed 2026-08-13 | $67.89M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $17.20M 10-Q · filed 2026-05-13 | $34.69M derived: sum of 2 quarters · filed 2026-05-13 | $49.66M derived: sum of 3 quarters · filed 2026-05-13 | $69.93M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $17.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $32.46M derived: sum of 2 quarters · filed 2026-03-19 | $52.74M derived: sum of 3 quarters · filed 2026-08-13 | $66.27M 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | $14.97M 10-Q · filed 2025-11-14 | $35.24M derived: sum of 2 quarters · filed 2026-08-13 | $48.78M 10-Q · filed 2025-11-14 | $66.70M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $20.28M 10-Q · filed 2026-08-13 | $33.81M 10-Q · filed 2026-08-13 | $51.73M derived: sum of 3 quarters · filed 2026-08-13 | $68.25M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $13.53M 10-Q · filed 2026-05-13 | $31.46M derived: sum of 2 quarters · filed 2026-05-13 | $47.98M derived: sum of 3 quarters · filed 2026-05-13 | $58.09M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $17.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $34.45M derived: sum of 2 quarters · filed 2026-03-19 | $44.55M derived: sum of 3 quarters · filed 2026-03-19 | $51.96M 10-K · filed 2026-03-19 | ||||
| 2024-09-30 | $16.52M 10-Q · filed 2025-11-14 | $26.63M derived: sum of 2 quarters · filed 2025-11-14 | $34.04M 10-Q · filed 2025-11-14 | $41.10M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | $10.11M 10-Q · filed 2025-08-14 | $17.52M 10-Q · filed 2025-08-14 | $24.58M derived: sum of 3 quarters · filed 2025-08-14 | $32.51M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $7.41M 10-Q/A · filed 2025-08-14 | $14.48M derived: sum of 2 quarters · filed 2025-08-14 | $22.41M derived: sum of 3 quarters · filed 2025-08-14 | $29.61M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2023-12-31 | $7.07M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-14 | $15.00M derived: sum of 2 quarters · filed 2025-08-14 | $22.20M derived: sum of 3 quarters · filed 2025-08-14 | $30.31M 10-K/A · filed 2025-08-14 | ||||
| 2023-09-30 | $7.93M 10-Q · filed 2024-11-12 | $15.13M derived: sum of 2 quarters · filed 2024-11-12 | $23.25M 10-Q · filed 2024-11-12 | $30.50M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $7.20M 10-Q · filed 2024-08-19 | $15.31M 10-Q · filed 2024-08-19 | $22.56M derived: sum of 3 quarters · filed 2024-08-19 | $30.02M derived: sum of 4 quarters · filed 2024-08-19 | ||||
| 2023-03-31 | $8.11M 10-Q/A · filed 2024-08-19 | $15.36M derived: sum of 2 quarters · filed 2024-08-19 | $22.82M derived: sum of 3 quarters · filed 2024-08-19 | $28.56M derived: sum of 4 quarters · filed 2024-08-19 | ||||
| 2022-12-31 | $7.25M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-19 | $14.70M derived: sum of 2 quarters · filed 2024-08-19 | $20.45M derived: sum of 3 quarters · filed 2024-08-19 | $27.08M 10-K/A · filed 2024-08-19 | ||||
| 2022-09-30 | $7.45M 10-Q · filed 2023-11-09 | $13.20M derived: sum of 2 quarters · filed 2023-11-09 | $19.83M 10-Q · filed 2023-11-09 | $26.01M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $5.74M 10-Q · filed 2023-08-10 | $12.38M 10-Q · filed 2023-08-10 | $18.56M derived: sum of 3 quarters · filed 2023-08-10 | $26.22M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $6.63M 10-Q · filed 2023-05-11 | $12.82M derived: sum of 2 quarters · filed 2023-05-11 | $20.48M derived: sum of 3 quarters · filed 2023-05-11 | $24.72M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $6.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $13.84M derived: sum of 2 quarters · filed 2023-03-30 | $18.08M derived: sum of 3 quarters · filed 2023-03-30 | $23.73M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $7.66M 10-Q · filed 2022-11-14 | $11.90M derived: sum of 2 quarters · filed 2022-11-14 | $17.55M 10-Q · filed 2022-11-14 | $20.59M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $4.24M 10-Q · filed 2022-08-11 | $9.89M 10-Q · filed 2022-08-11 | $12.93M derived: sum of 3 quarters · filed 2022-08-11 | $13.55M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $5.65M 10-Q · filed 2022-05-12 | $8.69M derived: sum of 2 quarters · filed 2022-05-12 | $9.30M derived: sum of 3 quarters · filed 2022-05-12 | $10.14M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $3.04M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $3.65M derived: sum of 2 quarters · filed 2022-03-24 | $4.48M derived: sum of 3 quarters · filed 2022-03-24 | $6.13M 10-K · filed 2022-03-24 | ||||
| 2020-09-30 | $615.00K 10-Q · filed 2021-11-12 | $1.45M derived: sum of 2 quarters · filed 2021-11-12 | $3.10M 10-Q · filed 2021-11-12 | $4.43M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $832.00K 10-Q · filed 2021-08-12 | $2.48M 10-Q · filed 2021-08-12 | $3.81M derived: sum of 3 quarters · filed 2021-08-12 | $5.32M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $1.65M 10-Q · filed 2021-05-14 | $2.98M derived: sum of 2 quarters · filed 2021-05-14 | $4.49M derived: sum of 3 quarters · filed 2021-05-14 | $6.79M derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $2.84M derived: sum of 2 quarters · filed 2021-03-31 | $5.14M derived: sum of 3 quarters · filed 2021-03-31 | $8.13M 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $1.51M 10-Q · filed 2020-11-16 | $3.81M derived: sum of 2 quarters · filed 2020-11-16 | $6.79M 10-Q · filed 2020-11-16 | $9.54M derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | $2.30M 10-Q · filed 2020-08-14 | $5.29M 10-Q · filed 2020-08-14 | $8.03M derived: sum of 3 quarters · filed 2020-08-14 | $9.68M derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | $2.99M 10-Q · filed 2020-05-15 | $5.73M derived: sum of 2 quarters · filed 2020-05-15 | $7.38M derived: sum of 3 quarters · filed 2020-05-15 | $8.71M derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | $2.74M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $4.39M derived: sum of 2 quarters · filed 2020-03-17 | $5.72M derived: sum of 3 quarters · filed 2020-03-17 | $6.82M 10-K · filed 2020-03-17 | ||||
| 2018-09-30 | $1.65M 10-Q · filed 2019-11-13 | $2.98M derived: sum of 2 quarters · filed 2019-11-13 | $4.08M 10-Q · filed 2019-11-13 | $4.57M derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2018-06-30 | $1.33M 10-Q · filed 2019-08-13 | $2.43M 10-Q · filed 2019-08-13 | $2.92M derived: sum of 3 quarters · filed 2019-08-13 | $3.44M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | $1.10M 10-Q · filed 2019-05-14 | $1.59M derived: sum of 2 quarters · filed 2019-05-14 | $2.11M derived: sum of 3 quarters · filed 2019-05-14 | $2.64M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $493.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $1.01M derived: sum of 2 quarters · filed 2019-03-28 | $1.54M derived: sum of 3 quarters · filed 2019-03-28 | $2.02M 10-K · filed 2019-03-28 | ||||
| 2017-09-30 | $517.00K 10-Q · filed 2018-11-13 | $1.05M derived: sum of 2 quarters · filed 2018-11-13 | $1.53M 10-Q · filed 2018-11-13 | $2.38M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $533.00K 10-Q · filed 2018-08-07 | $1.01M 10-Q · filed 2018-08-07 | $1.87M derived: sum of 3 quarters · filed 2018-08-07 | $2.92M derived: sum of 4 quarters · filed 2018-08-07 | ||||
| 2017-03-31 | $479.00K 10-Q · filed 2018-05-11 | $306.00K 10-Q · filed 2017-05-03 | $1.33M derived: sum of 2 quarters · filed 2018-05-11 | $2.39M derived: sum of 3 quarters · filed 2018-05-11 | $2.98M derived: sum of 4 quarters · filed 2018-05-11 | |||
| 2016-12-31 | $856.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $1.91M derived: sum of 2 quarters · filed 2018-04-02 | $2.50M derived: sum of 3 quarters · filed 2018-04-02 | $3.19M 10-K · filed 2018-04-02 | $25.02M 10-K · filed 2017-03-03 | |||
| 2016-09-30 | $1.05M 10-Q · filed 2017-11-08 | $6.16M 10-Q · filed 2016-11-03 | $1.65M derived: sum of 2 quarters · filed 2017-11-08 | $2.33M 10-Q · filed 2017-11-08 | $23.99M 10-Q · filed 2016-11-03 | $17.31M derived: sum of 4 quarters · filed 2017-11-08 | ||
| 2016-06-30 | $592.00K 10-Q · filed 2017-08-09 | $9.89M 10-Q · filed 2016-08-04 | $1.28M 10-Q · filed 2017-08-09 | $17.83M 10-Q · filed 2016-08-04 | $16.26M derived: sum of 3 quarters · filed 2017-08-09 | $24.75M derived: sum of 4 quarters · filed 2017-08-09 | ||
| 2016-03-31 | $7.93M 10-Q · filed 2017-05-03 | $15.66M derived: sum of 2 quarters · filed 2017-05-03 | $24.16M derived: sum of 3 quarters · filed 2017-05-03 | $30.01M derived: sum of 4 quarters · filed 2017-05-03 | ||||
| 2015-12-31 | $7.73M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $16.22M derived: sum of 2 quarters · filed 2017-03-03 | $22.08M derived: sum of 3 quarters · filed 2017-03-03 | $32.64M 10-K · filed 2017-03-03 | ||||
| 2015-09-30 | $8.49M 10-Q · filed 2016-11-03 | $14.35M derived: sum of 2 quarters · filed 2016-11-03 | $24.91M 10-Q · filed 2016-11-03 | $28.71M derived: sum of 4 quarters · filed 2017-03-03 | ||||
| 2015-06-30 | $5.86M 10-Q · filed 2016-08-04 | $16.41M 10-Q · filed 2016-08-04 | $20.22M derived: sum of 3 quarters · filed 2017-03-03 | $23.04M derived: sum of 4 quarters · filed 2017-03-03 | ||||
| 2015-03-31 | $10.56M 10-Q · filed 2016-05-10 | $14.36M derived: sum of 2 quarters · filed 2017-03-03 | $17.19M derived: sum of 3 quarters · filed 2017-03-03 | $21.58M derived: sum of 4 quarters · filed 2017-03-03 | ||||
| 2014-12-31 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $6.63M derived: sum of 2 quarters · filed 2017-03-03 | $11.02M derived: sum of 3 quarters · filed 2017-03-03 | $14.58M 10-K · filed 2017-03-03 | ||||
| 2014-09-30 | $2.83M 10-Q · filed 2015-11-10 | $7.22M derived: sum of 2 quarters · filed 2015-11-10 | $10.77M 10-Q · filed 2015-11-10 | $15.12M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-06-30 | $4.39M 10-Q · filed 2015-08-12 | $7.95M 10-Q · filed 2015-08-12 | $12.30M derived: sum of 3 quarters · filed 2016-03-10 | $15.00M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-03-31 | $3.56M 10-Q · filed 2015-05-12 | $7.91M derived: sum of 2 quarters · filed 2016-03-10 | $10.61M derived: sum of 3 quarters · filed 2016-03-10 | |||||
| 2013-12-31 | $4.35M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $7.05M derived: sum of 2 quarters · filed 2016-03-10 | $12.20M 10-K · filed 2016-03-10 | |||||
| 2013-09-30 | $2.70M 10-Q · filed 2014-11-13 | $7.85M 10-Q · filed 2014-11-13 | ||||||
| 2012-12-31 | $7.37M 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |